 5. Change in the dose one month prior to enrolment of other anticholinergic agents or other drugs potentially affecting saliva production, such as tricyclic antidepressants, MAO-A inhibitors, neuroleptics including clozapine and quetiapine more frequently used in PD or hypnotics. These medication will remain in a constant dose throughout the trial; 